CA2337964A1 - Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides - Google Patents

Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides Download PDF

Info

Publication number
CA2337964A1
CA2337964A1 CA002337964A CA2337964A CA2337964A1 CA 2337964 A1 CA2337964 A1 CA 2337964A1 CA 002337964 A CA002337964 A CA 002337964A CA 2337964 A CA2337964 A CA 2337964A CA 2337964 A1 CA2337964 A1 CA 2337964A1
Authority
CA
Canada
Prior art keywords
egf
polypeptide
injury
growth factor
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002337964A
Other languages
English (en)
French (fr)
Inventor
Seth P. Finklestein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2337964A1 publication Critical patent/CA2337964A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002337964A 1998-08-07 1999-08-06 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides Abandoned CA2337964A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9583098P 1998-08-07 1998-08-07
US60/095,830 1998-08-07
PCT/US1999/018022 WO2000007611A1 (en) 1998-08-07 1999-08-06 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides

Publications (1)

Publication Number Publication Date
CA2337964A1 true CA2337964A1 (en) 2000-02-17

Family

ID=22253781

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002337964A Abandoned CA2337964A1 (en) 1998-08-07 1999-08-06 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides

Country Status (4)

Country Link
EP (1) EP1100523A4 (ja)
JP (1) JP2002522394A (ja)
CA (1) CA2337964A1 (ja)
WO (1) WO2000007611A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1472375B1 (en) 2002-01-08 2009-04-01 Novartis Vaccines and Diagnostics, Inc. Gene products differentially expressed in cancerous breast cells and their methods of use
EP1449538A1 (en) 2003-02-21 2004-08-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
WO2015134869A2 (en) * 2014-03-06 2015-09-11 Children's National Medical Center Treatment of neonatal brain injury with hb-egf

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006705A1 (en) * 1990-10-16 1992-04-30 The Children's Medical Center Corporation Heparin binding mitogen with homology to epidermal growth factor (egf)

Also Published As

Publication number Publication date
WO2000007611A1 (en) 2000-02-17
EP1100523A1 (en) 2001-05-23
JP2002522394A (ja) 2002-07-23
EP1100523A4 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
JP4847634B2 (ja) 中枢神経系の虚血または外傷の機能的回復を増大させる方法
KR100334739B1 (ko) 절단된신경교세포주-유래신경영양성인자단백질산물
IE912793A1 (en) Chimeric neurotrophic factors
JP2003159083A (ja) 新規な神経栄養因子
US20110262432A1 (en) mutated netrin 4 proteins, fragments thereof and their uses as drugs
JP2001513334A (ja) ヘパリン結合増殖因子(hbgf)ポリペプチド
US8420780B2 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
US7129054B2 (en) Antibodies to a growth/differentiation factor of the TGF-β family
US6171584B1 (en) Method of treatment with growth/differentiation factors of the TGF-β family
CA2337964A1 (en) Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides
CA2216165C (en) Ndf peptides
US6080845A (en) Monoclonal antibody against utricular epithelium
Stortelers The role of EGF-like growth factors in selective ErbB receptor dimerisation

Legal Events

Date Code Title Description
FZDE Dead